Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick F Kiser

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|April 3, 2012
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infectionPedro M M Mesquita, Rachna Rastogi, Theodore J Segarra, et al.
Biomaterials|August 31, 2011
Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer systemAlamelu Mahalingam, Julie I Jay, Kristofer Langheinrich, et al.
Journal of Pharmaceutical Sciences|January 10, 2012
Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infectionAnthony S Ham, Shweta R Ugaonkar, Lianjun Shi, et al.
AIDS Research and Human Retroviruses|November 15, 2021
Conjoint Analysis of User Acceptability of Sustained Long-Acting Pre-Exposure Prophylaxis for HIVRobert J Schieffer, Ewa Bryndza Tfaily, Richard D'Aquila, et al.
Advanced Functional Materials|October 27, 2012
Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked HydrogelJulie I Jay, Shetha Shukair, Kristofer Langheinrich, et al.
AIDS Research and Human Retroviruses|September 20, 2018
Qualitative Consumer Research on Acceptance of Long-Acting Pre-Exposure Prophylaxis Products Among Men Having Sex with Men and Medical Practitioners in the United StatesBobby J Calder, Robert J Schieffer, Ewa Bryndza Tfaily, et al.
AIDS Research and Human Retroviruses|November 5, 2013
Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation propertiesKathleen M Morrow, Joseph L Fava, Rochelle K Rosen, et al.
Journal of Pharmaceutical Sciences|February 24, 2012
Design of tenofovir-UC781 combination microbicide vaginal gelsPatrick F Kiser, Alamelu Mahalingam, Judit Fabian, et al.
Pharmaceutical Research|April 17, 2020
Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide FumarateSolange M Simpson, Lakmini Widanapathirana, Jonathan T Su, et al.
AIDS Research and Human Retroviruses|September 30, 2022
Preferences Among Physicians and Men Who Have Sex with Men (MSM) for a Long-Acting, Removable Implant for HIV Prevention: A Discrete Choice StudyChristine Tagliaferri Rael, Rebecca Giguere, Sara Sutton, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|April 3, 2012
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infectionPedro M M Mesquita, Rachna Rastogi, Theodore J Segarra, et al.
Biomaterials|August 31, 2011
Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer systemAlamelu Mahalingam, Julie I Jay, Kristofer Langheinrich, et al.
Journal of Pharmaceutical Sciences|January 10, 2012
Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infectionAnthony S Ham, Shweta R Ugaonkar, Lianjun Shi, et al.
AIDS Research and Human Retroviruses|November 15, 2021
Conjoint Analysis of User Acceptability of Sustained Long-Acting Pre-Exposure Prophylaxis for HIVRobert J Schieffer, Ewa Bryndza Tfaily, Richard D'Aquila, et al.
Advanced Functional Materials|October 27, 2012
Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked HydrogelJulie I Jay, Shetha Shukair, Kristofer Langheinrich, et al.
AIDS Research and Human Retroviruses|September 20, 2018
Qualitative Consumer Research on Acceptance of Long-Acting Pre-Exposure Prophylaxis Products Among Men Having Sex with Men and Medical Practitioners in the United StatesBobby J Calder, Robert J Schieffer, Ewa Bryndza Tfaily, et al.
AIDS Research and Human Retroviruses|November 5, 2013
Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation propertiesKathleen M Morrow, Joseph L Fava, Rochelle K Rosen, et al.
Journal of Pharmaceutical Sciences|February 24, 2012
Design of tenofovir-UC781 combination microbicide vaginal gelsPatrick F Kiser, Alamelu Mahalingam, Judit Fabian, et al.
Pharmaceutical Research|April 17, 2020
Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide FumarateSolange M Simpson, Lakmini Widanapathirana, Jonathan T Su, et al.
AIDS Research and Human Retroviruses|September 30, 2022
Preferences Among Physicians and Men Who Have Sex with Men (MSM) for a Long-Acting, Removable Implant for HIV Prevention: A Discrete Choice StudyChristine Tagliaferri Rael, Rebecca Giguere, Sara Sutton, et al.
Pageof 6